The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5′ splice site strength
Open accessAbstract
BACKGROUND: Sequential assembly of the human spliceosome on RNA transcripts regulates splicing across the human transcriptome. The core spliceosome component PRPF8 is essential for spliceosome assembly through its participation in ribonucleoprotein (RNP) complexes for splice-site recognition, branch-point formation and catalysis. PRPF8 deficiency is linked to human diseases like retinitis pigmentosa or myeloid neoplasia, but its genome-wide effects on constitutive and alternative splicing remain unclear. RESULTS: Here, we show that alterations in RNA splicing patterns across the human transcriptome that occur in conditions of restricted cellular PRPF8 abundance are defined by the altered splicing of introns with weak 5' splice sites. iCLIP of spliceosome components reveals that PRPF8 depletion decreases RNP complex formation at most splice sites in exon-intron junctions throughout the genome. However, impaired splicing affects only a subset of human transcripts, enriched for mitotic cell cycle factors, leading to mitotic arrest. Preferentially retained introns and differentially used exons in the affected genes contain weak 5' splice sites, but are otherwise indistinguishable from adjacent spliced introns. Experimental enhancement of splice-site strength in mini-gene constructs overcomes the effects of PRPF8 depletion on the kinetics and fidelity of splicing during transcription. CONCLUSIONS: Competition for PRPF8 availability alters the transcription-coupled splicing of RNAs in which weak 5' splice sites predominate, enabling diversification of human gene expression during biological processes like mitosis. Our findings exemplify the regulatory potential of changes in the core spliceosome machinery, which may be relevant to slow-onset human genetic diseases linked to PRPF8 deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Altered splicing after PRPF8 depletion affects only a subset of human transcripts. a Intronic expression levels across the genome are increased in PRPF8-depleted cells. Normalized intron expression was calculated following analysis of the transcriptome of PRPF8-depleted Cal51 cells using RNA sequencing (left; “Materials and methods”). Statistically significant pairwise comparison is indicated (***p < 0.001). The number of mapped reads, the percentage of reads that map to exons, exon–intron boundaries, and intron bodies are shown in tabular form (right). b RNA sequencing experiments demonstrate that PRPF8 depletion results in altered splicing in only a subset of human transcripts. DEXSeq (“Materials and methods”) identifies a set of 2086 protein-coding genes that contain at least one retained intron [false discovery rate (FDR) < 0.01] and a set of 1921 protein-coding genes that display significant differences in exon usage (FDR < 0.01) following PRPF8 depletion; 637 genes display both retained introns and alternative exon usage (p < 2.2e-16). Transcripts with altered splicing patterns constitute only a subset of all expressed protein-coding genes (n = 3388 out of 13,216; expression threshold = 1 FPKM (Fragments per kilobase of exon per million reads mapped); “Materials and methods”). c Functional enrichment analysis using DAVID and WebGestalt (“Materials and methods”) shows that this subset is enriched for transcripts that participate in mitosis, ubiquitin conjugation, or RNA processing. GO Gene Ontology](https://figures.cochat.ai/paper-figures/2d143bb8a0f54d02911d40433d1a9899/regulation-of-constitutive-and-alternative-mrna-splicing-across-the-human-figure-2.jpg)





![Fig. 8 PRPF8 depletion alters the dynamics of RNA splicing during transcription. a, b Intronic reads contain potential information on the dynamics of splicing. Introns located towards the 5′ end of transcripts have a higher probability of being spliced out under a scenario of co-transcriptional splicing, but this is not the case if splicing occurs post-transcriptionally. A co-transcriptional splicing ratio was calculated by comparing the intronic coverage of the first versus last introns in each transcript, as indicated in (b), with the values used to calculate the ratio shown schematically in (a). Such coverage was normalized to take into account intron length and the expression levels of adjacent exons. A representative example is shown in (a), with first and last intronic reads indicated by arrowheads. RPKM Reads per kilobase of exon per million reads mapped. c Distribution of the co-transcriptional splicing ratio in control siRNA-treated and PRPF8-depleted samples. Co-transcriptional splicing dominates in control siRNA-treated samples as indicated by the low ratio values. The co-transcriptional splicing ratio significantly increases following PRPF8 depletion, suggesting disruptions in the co-transcriptional splicing efficiency (p < 5.34 × 10−9). Only genes with one transcript annotated in Ensembl 66 were considered for this analysis (n = 2366; “Materials and methods”). d PRPF8 depletion alters the dynamics of RNA splicing during transcription. The kinetics of transcription and splicing recovery of CDC20, APC8, and ASPM genes following release from drug-induced transcriptional arrest were measured in control siRNA-treated and PRPF8-depleted cells using a previously published protocol [37]. Primer pairs used are indicated and were chosen to measure the dynamics of RNA splicing of introns that are either retained or exons that are differentially used as determined by RNA sequencing experiments. As a control, the kinetics of splicing of an exon that was not differentially used in the ASPM transcript was also measured. PRPF8 depletion inhibits the kinetics of splicing as the delay between detection of the unspliced nascent transcript (indicated in black) and the partially spliced transcript (indicated in light gray) is ~20 minutes for CDC23 and ~15 minutes for ASPM in control siRNA-treated cells, but in excess of 40 minutes in PRPF8-depleted cells. In contrast, the kinetics of splicing and removal of intron 1 in the ASPM transcript is similar in both conditions. mRNA expression levels were normalized to non-DRB-treated cells for each condition (control siRNA-treated and PRPF8-depleted cells), which were harvested alongside the cells just released from DRB (0 minute time-point). DRB 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside](https://figures.cochat.ai/paper-figures/05bd569d36a04a1caf64bfc7032cfa79/regulation-of-constitutive-and-alternative-mrna-splicing-across-the-human-figure-8.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which constitute only a subset of all expressed protein-coding genes (13,216 genes; expression threshold = 1 fragments per kilobase million [FPKM]) (Wickramasinghe et al., 2015).”
From Impact of Alternative Splicing on the Human Proteome (2017) · cites this paper as Wickramasinghe et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Thus, using DEXSeq (Anders et al., 2012), we previously identified 3,370 transcripts with altered splicing patterns after PRPF8 depletion (1,284 with differential exon usage, 1,449 with intron retention, 637 with both), which constitute only a subset of all expressed protein-coding genes (13,216 genes; expression threshold = 1 fragments per kilobase million [FPKM]) (Wickramasinghe et al., 2015).”
From Impact of Alternative Splicing on the Human Proteome (2017) · cites this paper as Wickramasinghe et al., 2015
In the citing paper
“Transcript levels of differently used transcripts were validated by RT-PCR (see Figure 5 and Wickramasinghe et al., 2015 for differently used mitotic transcripts) and genes with differential expression were validated by qRT-PCR (see Figure S5C).”
From Impact of Alternative Splicing on the Human Proteome (2017) · cites this paper as Wickramasinghe et al., 2015
In the citing paper
“Following PRPF8 depletion, we see an increase in the expression levels of intronic reads throughout the genome (p value < 2.2 × 10−16) (Wickramasinghe et al., 2015).”
From Impact of Alternative Splicing on the Human Proteome (2017) · cites this paper as Wickramasinghe et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Cited by
Goodall, G. J., & Wickramasinghe, V. O. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,066
Self-citationLessons from non-canonical splicing
Sibley, C. R., Blazquez, L., & Ule, J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.46 · Cited by 316
Self-citationDefective control of pre–messenger RNA splicing in human disease
Chabot, B., & Shkreta, L. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 213
Alternative Splicing and Protein Diversity: Plants Versus Animals
Chaudhary, S., Khokhar, W., Jabre, I., Reddy, A. S. N., Byrne, L. J., Wilson, C. M., & Syed, N. H. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00708 · Cited by 205
Impact of Alternative Splicing on the Human Proteome
Liu, Y., Gonzàlez-Porta, M., Santos, S., Brazma, A., Marioni, J. C., Aebersold, R., Venkitaraman, A. R., & Wickramasinghe, V. O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.025 · Cited by 190
Self-citation
Metadata
- Authors
- Wickramasinghe, V. O., Gonzàlez-Porta, M., Perera, D., Bartolozzi, A. R., Sibley, C. R., Hallegger, M., Ule, J., Marioni, J. C., & Venkitaraman, A. R.
- Affiliations
- University of Cambridge (GB)
- European Bioinformatics Institute (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- Corresponding author
- Venkitaraman, Ashok R.
- ORCID
- Venue
- Genome Biology
- Published
- 2015-09-21
- Volume
- 16
- Issue
- 1
- Pages
- 201-201
- ISSN
- 1465-6906 (ISSN-L)
- 1474-760X
- PMC
- PMC4578845
- OpenAlex
- W2157561436
- Cited by
- 91
- References
- 72
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 9 · 2017: 9 · 2016: 5 · 2015: 2
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Genome biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_12022/8, MC_UU_12022/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- PRPF8, alternative splicing, constitutive splicing, spliceosome assembly, ribonucleoprotein complexes, iCLIP, intron retention, mitotic cycle, mitotic arrest, splice site recognition, retinitis pigmentosa, myeloid neoplasms
- MeSH terms
- Exons, Humans, Introns, Mutation, Retinitis Pigmentosa, Ribonucleoproteins, RNA, Messenger, RNA-Binding Proteins, Genome, Spliceosomes, Alternative Splicing, RNA Splice Sites, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5′ splice site strength. https://app.cochat.ai/papers/10.1186/s13059-015-0749-3
- The paper
- Wickramasinghe, V. O., Gonzàlez-Porta, M., Perera, D., Bartolozzi, A. R., Sibley, C. R., Hallegger, M., Ule, J., Marioni, J. C., & Venkitaraman, A. R. (2015). Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5′ splice site strength. Genome Biology. https://doi.org/10.1186/s13059-015-0749-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.